Dr. Regenold GmbH is specialised in national and international regulatory affairs. Founded in 1994, Dr Regenold GmbH has helped many clients gain marketing authorisations, both nationally and internationally, for their product developments.
Recognising clients’ needs for pan-European and global product registrations, Dr. Regenold founded regulanet®, a network of regulatory affairs consultancies with members in over 90 countries throughout the world. Established in 2001, member companies offer services to a wide variety of national and international healthcare and pharmaceutical clients, helping them understand the complexities of the different regulatory requirements and providing solutions.
The core service of Dr. Regenold GmbH is regulatory affairs specialising in several product categories from prescription medicines, OTCs, medical devices through to food supplements. Building upon this and in response to client feedback and demand, the services have now been expanded to include Market Access, Portfolio Analysis and Life Cycle Management.
By gaining an understanding of clients’ commercial needs, the key decision makers and route to market, Dr Regenold GmbH is able to recommend regulatory and market access solutions which help clients bring their products efficiently to market and maximise value from their asset.
Dr. Regenold GmbH is therefore a 'one stop shop' for national and international regulatory affairs, strategic advice and implementation.
To learn more about our company and services have a browse through the website or download our two page company leaflet:
|Dr. Regenold GmbH leaflet (09.10.2012)|